Pyruvate kinase M2 and Serine Dehydratase are Upregulated in the Macrophages of Human Aortic Atherosclerotic Lesions via Inflammatory Stimuli
Abstract
AIM: An altered vascular metabolism is closely linked to the cellular function in atherosclerotic lesions. The plasma pyruvate levels have been associated with aortic aneurysm progression in clinical studies. Pyruvate kinase M2 (PKM2) and serine dehydratase (SDS) catalyze the final steps of pyruvate production. While PKM2's role has been examined in experimental atherosclerosis or aneurysms, the involvement of SDS in atherosclerosis and the expression of PKM2 and SDS in human aortic lesions remain unknown. METHODS: Human aortic samples from vascular surgery were classified as early (n = 10), advanced (n = 9), or aneurysmal (n = 15) lesions. PKM2 and SDS expression were analyzed using immunohistochemistry. RESULTS: Immunopositive areas for these enzymes were larger in advanced and aneurysmal lesions than in early lesions and were predominantly expressed in macrophages. PKM2 was also detected in some smooth muscle cells and lymphocytes. In cultured human monocyte-derived macrophages, stimulation with tumor necrosis factor-α and interferon-γ increased the PKM2 and SDS expression levels. PKM2 silencing enhanced monocyte chemoattractant protein-1, interleukin-6, and SDS expression, and reduced transforming growth factor-β expression. SDS silencing significantly reduced the reactive oxygen species levels. CONCLUSIONS: The PKM2 and SDS expression levels increase in advanced human aortic atherosclerotic lesions and they are predominantly expressed in macrophages. The inflammatory microenvironment in atherosclerotic lesions upregulates the PKM2 and SDS expression in human macrophages. PKM2 may act as a negative regulator of vascular inflammation, and SDS may affect oxidative stress in inflammatory-stimulated macrophages.
Related
- Bcl-x Inactivation in Macrophages Accelerates Progression of Advanced Atherosclerotic Lesions in Apoe −/− Mice
- Identification and characterization of inflammatory LILR and fibrotic SPP1 macrophages in chronic lung allograft dysfunction
- Extract-equivalent decursin and decursinol angelate reproduce major anti-inflammatory effects of Angelica gigas root ethanol extract in LPS-stimulated macrophages
- Low-molecular-weight Ulva lacinulata extract exhibiting anti-inflammatory and pro-autophagic activities in RAW 264.7 macrophages: a promising candidate for the development of active ingredients targeting low-grade inflammation
- Anti-inflammatory macrophages limit endothelial inflammation and restrict neutrophil recruitment through Gas6/AXL signaling
BibTeX
@article{nakamura2026pyruvate,
title = {{Pyruvate kinase M2 and Serine Dehydratase are Upregulated in the Macrophages of Human Aortic Atherosclerotic Lesions via Inflammatory Stimuli}},
author = {Eriko Nakamura and Masanori Nishimura and Kazunari Maekawa and Toshihiro Gi and Nobuyuki Oguri and Murasaki Aman and Sayaka Moriguchi-Goto and Michikazu Nakai and Koji Furukawa and Atsushi Yamashita},
journal = {Journal of Atherosclerosis and Thrombosis},
year = {2026},
month = jul,
doi = {10.5551/jat.66119},
url = {https://www.jstage.jst.go.jp/article/jat/advpub/0/advpub_66119/_article},
note = {CC BY-NC-SA},
}
RIS
TY - JOUR
TI - Pyruvate kinase M2 and Serine Dehydratase are Upregulated in the Macrophages of Human Aortic Atherosclerotic Lesions via Inflammatory Stimuli
AU - Eriko Nakamura
AU - Masanori Nishimura
AU - Kazunari Maekawa
AU - Toshihiro Gi
AU - Nobuyuki Oguri
AU - Murasaki Aman
AU - Sayaka Moriguchi-Goto
AU - Michikazu Nakai
AU - Koji Furukawa
AU - Atsushi Yamashita
PY - 2026
DA - 2026/07/08
JO - Journal of Atherosclerosis and Thrombosis
DO - 10.5551/jat.66119
UR - https://www.jstage.jst.go.jp/article/jat/advpub/0/advpub_66119/_article
AB - AIM: An altered vascular metabolism is closely linked to the cellular function in atherosclerotic lesions. The plasma pyruvate levels have been associated with aortic aneurysm progression in clinical studies. Pyruvate kinase M2 (PKM2) and serine dehydratase (SDS) catalyze the final steps of pyruvate production. While PKM2's role has been examined in experimental atherosclerosis or aneurysms, the involvement of SDS in atherosclerosis and the expression of PKM2 and SDS in human aortic lesions remain unknown. METHODS: Human aortic samples from vascular surgery were classified as early (n = 10), advanced (n = 9), or aneurysmal (n = 15) lesions. PKM2 and SDS expression were analyzed using immunohistochemistry. RESULTS: Immunopositive areas for these enzymes were larger in advanced and aneurysmal lesions than in early lesions and were predominantly expressed in macrophages. PKM2 was also detected in some smooth muscle cells and lymphocytes. In cultured human monocyte-derived macrophages, stimulation with tumor necrosis factor-α and interferon-γ increased the PKM2 and SDS expression levels. PKM2 silencing enhanced monocyte chemoattractant protein-1, interleukin-6, and SDS expression, and reduced transforming growth factor-β expression. SDS silencing significantly reduced the reactive oxygen species levels. CONCLUSIONS: The PKM2 and SDS expression levels increase in advanced human aortic atherosclerotic lesions and they are predominantly expressed in macrophages. The inflammatory microenvironment in atherosclerotic lesions upregulates the PKM2 and SDS expression in human macrophages. PKM2 may act as a negative regulator of vascular inflammation, and SDS may affect oxidative stress in inflammatory-stimulated macrophages.
SN - 1880-3873
SN - 1340-3478
ER -